News Live

CARsgen® U.S. Clinical Holds Lifted by FDA

CARsgen Therapeutics

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 179 180 181 182 183 184 185 Next Tail

10 Items Per Page (Page 182 / 540) Total 5393 Items